Last reviewed · How we verify
NCT03769012
Ability of Beta-glucan Supplementation to Augment Immune Function
NA trial testing Beta-Glucan in Cold in 60 participants. Completed in 30 May 2020.
30 November 2019
Quick facts
| Lead sponsor | Kemin Foods LC |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | other |
| Enrollment | 60 |
| Start date | 27 December 2018 |
| Primary completion | 30 November 2019 |
| Estimated completion | 30 May 2020 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Beta-Glucan — full drug profile →
- Placebo
Conditions studied
- Cold — all drugs for Cold →
- Cold Symptom — all drugs for Cold Symptom →
- Flu — all drugs for Flu →
- Flu Symptom — all drugs for Flu Symptom →
Sponsor
Kemin Foods LC
Who can join
Adults 21 to 65, any sex, with Cold or Cold Symptom. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This proposed study is designed to assess the efficacy of a capsule containing beta-glucan taken orally daily as compared to a placebo capsule on the URTI symptoms, and the immune response change in marathon runners
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03769012
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Beta-Glucan
Trials testing the same drug.
- NCT04513028 — Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma · NA · recruiting
- NCT04710290 — A Cohort Study of Beta-Glucan or Beta-Glucan Compound in Metastatic Cancers · Phase 2, PHASE3 · unknown
Other recruiting trials for Cold
Currently open trials in the same condition.
- NCT06704698 — Postoperative Analgesia Between Paravertebral Block and Epidural Block in Esophageal Surgery · NA · recruiting
- NCT06507761 — Thermotherapy in Acute Nonspecific Neck Pain · NA · recruiting
Other Kemin Foods LC trials
Trials by the same sponsor.
- NCT06397482 — Effects of an Encapsulated Calcium Butyrate Dietary Supplement on Gut Health · NA · completed
- NCT04735809 — Efficacy of a Whole Cell Algae Fermentate on Gut Health and Overall Immune Function in Healthy Adults With Mild Gastroin · NA · completed
- NCT03769779 — Evaluation of the Benefits of FloraGLO™ Lutein on Skin Health · NA · completed
- NCT03518281 — Ability of a Euglena Beta Glucan Supplementation to Augment Immune Function · NA · completed
- NCT03113864 — Effects of Lutein on Visual Function · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03769012 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kemin Foods LC
- Last refreshed: 3 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03769012.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing